Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
285.20    -1.70 (-0.59%)
Bid:
285.30
Ask:
285.40
Spread: 0.10 (0.035%)
Market Cap: £15.63b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Director/PDMR Shareholding

20 Jun 2024 18:15

RNS Number : 2892T
Legal & General Group Plc
20 June 2024
 

 

Legal & General Group Plc

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

The following notification made under article 19 of the UK Market Abuse Regulation ("UK MAR") relates to the award of restricted shares on 18 June 2024. On 19 June 2024, Legal & General Group Plc (the "Company") received notification that on 18 June 2024 the PDMRs named below had been awarded restricted shares at a price of £2.2533 per ordinary share under the terms of the Share Bonus Plan ("SBP"). All SBP awards vest on 8 April 2027.

 

 

Name

Director/ PDMR

Number of SBP Restricted Shares awarded on 18 June 2024 at a price of £2.2533

Laura Mason

PDMR

167,746

Andrew Kail

PDMR

167,746

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 1. Laura Mason

 2. Andrew Kail

 

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer, Private Markets/PDMR

 

2. Chief Executive Officer, Legal & General Retirement Institutional/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Legal & General Group Plc

b)

LEI

213800JH9QQWHLO99821

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.025 each, with voting rights attached

 GB0005603997

b)

Nature of transaction

SBP restricted shares award for the PDMRs listed in 1a above

 

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. £2.2533

1. 167,746

2. £2.2533

2. 167,746

d)

Aggregated information

- Aggregated volume

- Price

 N/A (Single Transaction)

e)

Date of the transaction

18 June 2024

f)

Place of the transaction

London Stock Exchange, XLON

 

 

 

 

 

20 June 2024

 

Leanne Cornish

Head of Group Secretariat

Legal & General Group Plc

 

Tel: 020 3124 4111

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQBLFLZQLLBBF
Date   Source Headline
9th Apr 20245:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSTotal Voting Rights
21st Mar 20249:00 amRNSDirector/PDMR Shareholding
13th Mar 202410:30 amRNSAnnual Financial Report
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 2
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 1
4th Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSTotal Voting Rights
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
27th Feb 20249:00 amRNSChange of Group Remuneration Committee Chair
23rd Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20245:00 pmRNSDirector Declaration
2nd Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSTotal Voting Rights
5th Jan 20245:00 pmRNSBlock listing Interim Review
3rd Jan 20245:00 pmRNSDirector/PDMR Shareholding
4th Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSL&G agrees full buy-in for Boots Pension Scheme
9th Nov 20239:00 amRNSDirector Declaration
2nd Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSTotal Voting Rights
1st Nov 20235:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSTotal Voting Rights
2nd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSDirector/PDMR Shareholding
28th Sep 20235:00 pmRNSDirector/PDMR Shareholding
28th Sep 20235:00 pmRNSDirector Declaration
28th Sep 20235:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:00 amRNSChange of Senior Independent Director
4th Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSTotal Voting Rights
15th Aug 20237:00 amRNSL&G Half Year Results 2023 Part 2
15th Aug 20237:00 amRNSL&G Half Year Results 2023 Part 1
2nd Aug 20235:00 pmRNSDirector/PDMR Shareholding
1st Aug 20235:00 pmRNSDirector/PDMR Shareholding
1st Aug 20235:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.